Skip to main content
Clinical Trials/ITMCTR2000003938
ITMCTR2000003938
Recruiting
Phase 1

Clinical observation on the therapeutic effect of 'three-part acupoint combination' combined with Aili eye drops in the treatment of perimenopausal dry eye syndrome.

Conditionsdry eye disease

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
dry eye disease
Sponsor
Shanghai General Hospital
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Meet the above diagnostic criteria of perimenopausal dry eye with deficiency of liver and kidney Yin;
  • (2\) If the western medicine eye drops are used for treatment before enrollment, the drug should be stopped for at least three weeks or more; in addition, the patient has not participated in other therapies or other clinical studies within three months;
  • (3\) Non\-allergic constitution;
  • (4\) Voluntary participation and signing of informed consent.

Exclusion Criteria

  • (1\) Patients with other eye diseases, such as congenital tear deficiency, lacrimal duct obstruction, severe trachoma, keratopathy, conjunctival scarring, conjunctival lesions and other eye diseases, and subjects undergoing eye surgery;
  • (2\) Combined with dry mouth, joint pain and dry skin, considered as sjogren's syndrome caused by dry eyes;
  • (3\) Subjects during pregnancy and lactation;
  • (4\) Subjects with severe systemic diseases, such as cardiovascular and cerebrovascular diseases, severe liver and kidney dysfunction, and coagulation dysfunction;
  • (5\) Subjects with mental disorders or psychological disorders who cannot cooperate with the treatment and study;
  • (6\) Contact lens wearer.

Outcomes

Primary Outcomes

Not specified

Similar Trials